ST. LOUIS, March 18 /PRNewswire-FirstCall/ -- Sigma-Aldrich announced today that it has amended the terms of its $300 million revolving credit facility established in December 2006 by exercising $150 million of the facility accordion feature. Under the revised $450 million revolving credit facility, $30 million will mature on December 11, 2011 and $420 million will mature on December 11, 2012. The facility will provide back-up liquidity for the commercial paper program that has been expanded to the $450 million level and be used for general corporate purposes.
Wells Fargo Bank, National Association and Bank of America, N.A. served as co-arrangers for the eight-bank syndicate participating in this facility. Wells Fargo Bank, National Association acted as the administrative agent.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service.
CONTACT: Kirk A. Richter, Treasurer of Sigma-Aldrich, +1-314-286-8004
Web site: http://www.sigma-aldrich.com/
